The Edward B. Bromfield Epilepsy Program at Brigham and Women’s Hospital offers state of the art clinical diagnostics, treatment and chronic care for people with epilepsy, a disease that affects nearly three million people in the United States. The Program brings together a group of specialists from a variety of disciplines who share the goal of eliminating seizures in the safest and most effective way, while elevating quality-of-life for all of our patients. Our multidisciplinary approach integrates the expertise of the internationally renowned BWH clinical staff including dedicated neurologists, neurosurgeons, psychiatrists, neuropsychologists, social workers, nurse specialists and electroencephalography (EEG) technologists, all with special training and expertise in epilepsy.
Our team is equipped to care for patients with even the most complex conditions and symptoms. Brigham and Women’s Hospital is a level IV nationally accredited center that offers state-of-the-art care to those with difficult-to-control refractory seizures. Additionally, BWH is home to the most advanced brain imaging technologies available, which allow us to map the brain with the most precise detail and pinpoint areas where seizures originate, and, thus, perform surgery without disrupting important brain function. We also understand that a condition such as epilepsy can cause tremendous challenges and it is critical to treat the whole patient. In addition to medical care, we provide psychiatric, psychological and social support to individuals and their families.
Learn more about new research findings debunking the idea that Epilepsy can hamper fertility.
The Edward B. Bromfield Epilepsy Program at Brigham and Women’s Hospital offers epilepsy patients long-term continuous video EEG monitoring. The goal of this evaluation is to record a patient’s typical seizures using a video camera and continuous EEG monitoring to help better diagnose and improve treatment.
The A.J. Trustey Epilepsy Research Endowed Fund at Brigham and Women’s Hospital was established by the Trustey family to support innovative epilepsy research with the goal of transforming care for the millions who confront this devastating disease.